Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Rees

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Current Opinion in Lipidology|September 11, 2009
Therapy and clinical trials: Familial hypercholesterolaemia and prevention of coronary artery diseaseManeesh V Udiawar, Alan Rees
Current Opinion in Lipidology|November 21, 2002
The future direction of cholesterol-lowering therapyMarc Evans, Aled Roberts, Alan Rees
Current Opinion in Lipidology|July 9, 2008
Nutrition and metabolismAled Roberts, Shihong Chen, Alan Rees
Drugs|May 27, 2004
Medical lipid-regulating therapy: current evidence, ongoing trials and future developmentsMarc Evans, Aled Roberts, Steve Davies, et al.
Current Opinion in Lipidology|May 9, 2014
Management of homozygous familial hypercholesterolaemiaVinay S Eligar, Laxmi N R Bondugulapati, Alan Rees
Current Opinion in Lipidology|November 19, 2003
Peroxisome proliferator-activated receptor-gamma agonists in atherosclerosis: current evidence and future directionsAled W Roberts, Andrew Thomas, Alan Rees, et al.
Current Opinion in Lipidology|May 9, 2014
Bariatric surgery and cardiovascular risk reductionLaxmi Narsimha Rao Bondugulapati, Vinay S Eligar, Alan Rees
QJM : Monthly Journal of the Association of Physicians|December 3, 2010
In defence of obsolete dataDavid J Galton, Alan Rees, Gordon A A Ferns
Current Opinion in Lipidology|July 9, 2010
Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemiaBorunendra N Datta, Ian F W McDowell, Alan Rees
Current Vascular Pharmacology|January 20, 2009
Postprandial glucose - a potential therapeutic target to reduce cardiovascular mortalityRaj Peter, Onyebuchi E Okoseime, Alan Rees, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Current Opinion in Lipidology|September 11, 2009
Therapy and clinical trials: Familial hypercholesterolaemia and prevention of coronary artery diseaseManeesh V Udiawar, Alan Rees
Current Opinion in Lipidology|November 21, 2002
The future direction of cholesterol-lowering therapyMarc Evans, Aled Roberts, Alan Rees
Current Opinion in Lipidology|July 9, 2008
Nutrition and metabolismAled Roberts, Shihong Chen, Alan Rees
Drugs|May 27, 2004
Medical lipid-regulating therapy: current evidence, ongoing trials and future developmentsMarc Evans, Aled Roberts, Steve Davies, et al.
Current Opinion in Lipidology|May 9, 2014
Management of homozygous familial hypercholesterolaemiaVinay S Eligar, Laxmi N R Bondugulapati, Alan Rees
Current Opinion in Lipidology|November 19, 2003
Peroxisome proliferator-activated receptor-gamma agonists in atherosclerosis: current evidence and future directionsAled W Roberts, Andrew Thomas, Alan Rees, et al.
Current Opinion in Lipidology|May 9, 2014
Bariatric surgery and cardiovascular risk reductionLaxmi Narsimha Rao Bondugulapati, Vinay S Eligar, Alan Rees
QJM : Monthly Journal of the Association of Physicians|December 3, 2010
In defence of obsolete dataDavid J Galton, Alan Rees, Gordon A A Ferns
Current Opinion in Lipidology|July 9, 2010
Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemiaBorunendra N Datta, Ian F W McDowell, Alan Rees
Current Vascular Pharmacology|January 20, 2009
Postprandial glucose - a potential therapeutic target to reduce cardiovascular mortalityRaj Peter, Onyebuchi E Okoseime, Alan Rees, et al.
Pageof 5